IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78

Chao Li(Eli Lilly (United States)), Youngman Oh(Virginia Commonwealth University), Aki Harada(Virginia Commonwealth University Medical Center)
Cancer Letters
July 16, 2012
Cited by 38


Related Papers